Physician profile
Philippe Desplat
NPI 1033166798
$2,948.64
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $1,254 · 2021: $748.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $573.14 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $439.48 | 2019-2021 | |
| Lilly USA, LLC | $311.92 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $223.16 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.56 | 2019-2021 | |
| Pfizer INC. | $217.71 | 2019-2021 | |
| Sanofi Pasteur INC. | $155.74 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $144.54 | 2019-2021 | |
| Glaxosmithkline, LLC. | $121.78 | 2019-2021 | |
| Amgen INC. | $110.34 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $80.52 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $79.31 | 2019-2021 | |
| Amarin Pharma, INC. | $76.78 | 2019-2021 | |
| Allergan, INC. | $60.75 | 2020 | |
| Abbvie INC. | $57.32 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $48.82 | 2019-2021 | |
| Circassia INC. | $14.15 | 2020 | |
| Horizon Therapeutics Plc | $12.62 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philippe Desplat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.